Variability in Interbeat Duration Influences Myocardial Contractility in Rat Cardiac Trabeculae by Torres, Carlos A. A et al.
100  The Open Cardiovascular Medicine Journal, 2008, 2, 100-104   
 
  1874-1924/08  2008 Bentham Open 
Open Access 
Variability in Interbeat Duration Influences Myocardial Contractility in 
Rat Cardiac Trabeculae 
Carlos A. A. Torres
1,2, Kenneth D. Varian
1 and Paul M. L. Janssen
1,* 
1Department of Physiology and Cell Biology, and 
2Department of Emergency Medicine 304 Hamilton Hall, 1645 Neil  
Avenue, The Ohio State University, Columbus, OH, USA 
Abstract: There is an intense search for positive inotropic strategies. It is well known that the interbeat duration is a criti-
cal determinant of cardiac contractility. Generally, when frequency increases, so does contractile strength. We hypothesize 
that the beat-to-beat variability at a given heart rate also modulates cardiac contractility. To test this hypothesis, thin, uni-
form rat cardiac trabeculae were isolated from the right ventricle and stimulated to isometrically contract, alternating be-
tween fixed steady state versus variable inter-beat intervals (same total number of beats in each period). Trabeculae were 
stimulated at 4 Hz with interbeat variation between 20 and 120% (n=17). In a second series of experiments trabeculae 
were stimulated at 3 different physiologic frequencies with a 40% interbeat variation. Fixed rate response was measured 
before and after each variable period and average force was calculated. In order to investigate the mechanism underlying 
the changes in contractility we used iontophoretically loaded bis-fura-2 salt to monitor intracellular calcium transients. We 
observed no significant change in force at 4 Hz (n=17), and 6 Hz (n=6) between fixed and variable pacing but observed a 
significant, 10% increase in contractile strength at 8 Hz (from 15.1 to 16.5 mN/mm
2, p<0.05, n=6). Our results show that 
under certain conditions, by simply introducing variation in the beat-to-beat duration without affecting the number of 
beats per minute, a positive inotropic effect with corresponding changes in the calcium transients can be generated. 
INTRODUCTION 
  The epidemic proportions that heart failure has reached 
in western society has prompted an intense search for posi-
tive inotropic therapies. Current approaches vary from phar-
macologic to mechanical to genetic manipulation. We sought 
to investigate if manipulating the R-R interval within physi-
ologic range may be a potential inotropic strategy. The influ-
ence of the duration between successive cardiac beats has 
long been known to be a strong determinant of contractility. 
Force-frequency relationships have been investigated at the 
level of the whole heart [1], as well as isolated tissue [2], and 
isolated cell level, in various species. These previous studies 
clearly indicate that within the physiological range, a de-
crease in inter-beat duration (i.e. increase in heart rate), re-
sults in an increase in contractility. However, this force-
frequency relationship only holds true for the steady-state 
that develops over many beats. Contractile strength on a 
beat-to-beat basis shows an opposite effect: the first beat(s) 
after switching to a higher stimulation rate are in fact weaker 
[3]. An instantaneous switch from a steady inter-beat-
duration to a shorter inter-beat period decreases force of con-
traction, while an increase in inter-beat period increases con-
traction, the latter is called post-rest potentiation [4]. In vivo, 
a small variation in inter-beat duration is normally observed, 
(beat-to-beat variability). Since force-frequency behavior 
and post-rest potentiation behavior are non-linear in the time 
domain, a given shortening of inter-beat duration does not 
necessarily cause an equal and opposite change in cardiac   
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contractility compared to an identical lengthening of inter-
beat duration. In addition, this non-linearity of the inter-beat 
interval to force relationship depends critically on the base-
line inter-beat duration (average heart rate). We thus postu-
late that a variable timing component superimposed on an 
average constant pacing rate does therefore not necessarily 
result in the same contractility observed at a fixed (non-
variable) identical pacing rate. In other words, average con-
tractile force may differ depending on presence and magni-
tude of beat-to-beat variability; If longer beats increase the 
force development by a greater magnitude than an identical 
shortening can cause a decrease in force development then it 
follows that the average force development in the variable 
period may exceed the one observed at the fixed rate period 
(both with identical number of beats) and over the same 
amount of time. 
  To test our hypothesis that interbeat variability can ac-
tively contribute to cardiac contractility, for proof-of-
principle, we isolated multicellular cardiac trabeculae, stimu-
lated them isometrically at fixed intervals, intercalated with 
protocols in which a variable inter-beat duration was im-
posed with identical average interval and total number of 
beats as the fixed rate. Our results indicate that under certain 
conditions that fall well within the physiological range beat-
to-beat variability plays a role as a determinant of myocar-
dial contractility. 
MATERIALS AND METHODOLOGY 
  Male Rats (LBN-f1 175-225 g) were anesthetized by 
intraperitoneal injection of sodium pentobarbital (60mg/kg). 
The investigation conforms with the Guide for the Care and 
Use of Laboratory Animals published by the US National 
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1996). After a bilateral thoracotomy, the hearts were 
heparinized by introducing a 25 gauge needle via the apex 
while still beating. Hearts were rapidly excised and placed in 
Krebs-Henseleit buffer containing: 120 mM NaCl, 5 mM 
KCl, 2 mM MgSO4, 1 mM NaH2PO4, 20 mM NaHCO3, 0.25 
mM Ca
2+, and 10 mM glucose in continuous equilibrium 
with 95% O2/5% CO2 resulting in a pH of 7.4. BDM (2,3-
butanedionemonoxime) 20mM was added to the dissection 
buffer to prevent cutting injury [5]. Thin (average diameter 
<150  m, to avoid core-hypoxia) [6, 7], uniform, non-
branched, trabeculae (n = 19) along the tricuspid valve were 
carefully dissected, their dimensions measured, and then 
mounted in the experimental set-up [8]. Trabeculae were 
perfused with the same buffer as above (without BDM) at 37 
°C, 1.5 mM Ca
2+, and allowed to stabilize for at least 30 min 
at 4 Hz. During stabilization, optimal muscle length was 
obtained by stretching muscles to where small increases in 
length resulted in about equal increases in resting tension 
and active developed tension. This fixed optimal preload is 
equivalent to that verified at the end diastolic volume of the 
in vivo situation (sarcomere length of ~2.2 m) [9]. 
  In the first group (n = 17), after 20 minutes of baseline 
stimulation at a fixed base frequency of 4 Hz, the trabeculae 
were stimulated for 2-minute periods alternating between a 
fixed steady state period (4 Hz) and a variable component 
period (10-120% of cycle length). Beat-to-beat variability 
was introduced by random stimuli intervals with algorithms 
such that over an identical time period there was an equal 
number of beats compared to the steady state. Each period of 
variation was both preceded and followed by a steady state 
period in order to help estimate general rundown (which is 
unavoidable in these preparations). In order to avoid comput-
ing the effects of post rest potentiation that might occur at 
the exact moment the protocols are switched from steady 
state to variable, the 2 initial beats were not taken into ac-
count during the calculations. For this proof-of-principle 
investigation, beat-to-beat variability was distributed line-
arly, and expressed as a percentage of the variation between 
the longest and shortest beat (e.g. at 40% variation at 4 Hz 
(R-R interval of 250 ms), the inter-beat duration varied be-
tween 200 and 300 ms). In the second group of experiments, 
trabeculae were stimulated at 4 Hz (n = 17), 6 Hz (n = 6) and 
8 Hz (n = 6), thereby encompassing the physiological range 
for the rat. The experimental period consisted of an imposed 
40% variability over the fixed (control) period. Once again, 
over an identical time period there was an equal number of 
beats both in the control and experimental protocols. Beat-
to-beat variability protocols were both preceded and fol-
lowed by fixed rate periods. The variables from the beat-to-
beat variability protocols were measured right after assess-
ment of the fixed-rate response at the same base frequency, 
allowing the assessment and potential correction of run-
down of the preparation. If rundown exceeded 20% per 5 
consecutive protocols, the trabeculae were discarded. As a 
surrogate for standardized measurements of heart rate vari-
ability in the time domain, we calculated the effective SDNN 
(standard deviation of normal to normal intervals) spanning 
each of the individual 2 minute variable periods at each base 
frequency. These were then averaged and labeled as 
SDNN(mod) index. 
  In a subsequent set of experiments (n = 3), intracellular 
calcium transients were measured after iontophoretic loading 
of the calcium indicator bis-Fura-2 into a preparation. The 
dye loading technique and protocol that allows for assess-
ment of calcium transients at body temperature has been 
described previously [8, 10]. Briefly, at room temperature, a 
micropipette filled with bis-Fura-2 is introduced into a single 
myocyte near the center of the preparation, and a small nega-
tive current is applied to introduce the dye into the cyto-
plasm.  Via gap-junctions this dye spreads to neighboring 
cells. Once the dye has uniformly spread (on average 30 
minutes), fluorescence intensity at 510 nm is measured dur-
ing alternate exposure to 340 and 380 nm excitation light. 
Trabeculae were then stimulated with the previously de-
scribed variable pacing protocols, Simultaneous force 
development and intracellular calcium transients were 
recorded at 37 °C. 
 Data  was  collected  via custom-written Labview
® pro-
grams, and stored for off-line analysis. Results are denoted 
as mean ± SEM unless stated otherwise. Wherever applica-
ble, paired or un-paired t-tests were performed, and a two-
tailed value of P<0.05 was taken as level for significance. 
RESULTS 
  In Fig. (1) we demonstrate that when pre-beat duration 
increased, so did contractile strength. In the depicted exam-
ple, at a frequency of 8 Hz (cycle time of 125 ms), a 40% 
variation was imposed, making the shortest beat-to-beat in-
terval 100 ms, and the longest interval 150 ms. The highest 
contractile force was observed after the longest pre-beat du-
ration (i.e. after the longest diastolic interval), whereas the 
shortest intervals were followed by the weakest beats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Force development is dependent on duration of the pre-
beat interval; when previous beat-duration increases, so does peak 
twitch force development (Fdev). In the depicted example, at a 
frequency of 8 Hz a 40% variation was imposed. Thus, inter-beat 
duration varied from 100 to 150 ms, with an average of 125 ms (=8 
Hz). 
  For each stimulation period, we averaged the mean 
twitch force. By comparing the developed force at 4 Hz be-
tween fixed and variable pacing we noticed small, increases 
in force due to variable pacing with a trend towards increas-
ing force with increasing varibility (with the notable excep-102    The Open Cardiovascular Medicine Journal, 2008, Volume 2  Torres et al. 
tion of 100% variability). The highest increase was noted at 
120% variability (+1.3%, SEM 1.0 n = 17, Fig. 2) although 
this did not achieve statistical significance.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). At a base cycle time of 250 ms (4 Hz), between 10 and 
120% variability (reflecting cycle times from 237.5-262.5 ms and 
125-375 ms resp.), the small increases in average Fdev were not 
significant, but on the other hand did not impair contractility either 
(n = 17). 
  The 40% variability index imposed during these proto-
cols is well within the normal physiologic intervals reported 
in the literature for rats whereas the 120% variability index 
exceeds the variations reported for ‘in vivo” experiments. 
[11] (Fig. 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). At a variability of 40% and for all frequencies observed 
(4,6,8) the SDNN(mod) was well within the physiologic range for 
rats. At 120% variability the SDNN(mod) was elevated. 
  The second experimental protocol group had baseline 
frequencies set at 4, 6 and 8 Hz during the fixed rate inter-
vals with the corresponding 40% variability algorithm im-
posed during alternate 2 minute periods. 
  Trabeculae, while exposed to variable beat-to-beat stimu-
lation protocol, showed a more substantial increase in Fdev 
from an average of 15.1 to 16.5 mN/mm
2, an average percen-
tile increase of 10.1% (P<0.05, n = 7, SEM 1.9) at 8 Hz (Fig. 
4) when compared to their fixed-rate stimulation averages. 
This indicates that despite the fact that the number of beats 
per minute was the same, beat-to-beat variability increased 
contractility.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). At a variability of 40%, average active developed force 
again was not significantly increased at an average cycle time of 4 
and 6 Hz however at the 8 Hz, the 40% variability significantly 
increased the average developed force of the trabeculae, * (P<0.05, 
n = 7). 
  When beat-to-beat variability is imposed on cardiac tra-
beculae the effect of these interval dependent changes on the 
calcium transients can be seen in Fig. (5). In Fig. (5A), a 
positive correlation between the developed calcium transient 
amplitude and force of contraction (Fdev) was observed 
(P<0.05) under all tested conditions. In Fig. (5B) we demon-
strate the positive correlation between a longer cycle length 
(pre-beat duration) with an increase in the corresponding 
calcium transient. In addition in Fig. (5C) the variations in 
interbeat duration and their associated fluctuations in the 
amplitude of the calcium transients are depicted. 
  When an inter-beat period exceeds the fixed-rate, the 
following stimulation results in an increase in amplitude of 
contracture. A beat that is shorter than the fixed-rate gener-
ally results in a decrease of contraction. However, as was the 
case for data obtained at a variability of 40% at 6 and 8 Hz, 
these deviations from the fixed-rate average are not necessar-
ily of identical magnitude. Thus, the absolute extra strength 
generated by long beats appears to be greater than the abso-
lute loss by an equivalently shorter beat with corresponding 
changes in the calcium transients. On average, the introduc-
tion of variability can result in amplitudes of contraction 
during variable pacing that, on average, exceed the ampli-
tude during the fixed-rate pacing protocol. 
DISCUSSION 
  We set out to observe whether a small variation in the 
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effect on cardiac contractility. We showed that a non-
variable pacing algorithm can indeed alter myocardial 
contractile strength, and thus we demonstrate for the first 
time that beat-to-beat variability is a direct and positive 
modulator of cardiac contractility. Results from isolated 
muscle preparations including those regarding the interval-
force relationship have been well substantiated by other 
investigators utilizing different models [12]; the multicellular 
preparation has been validated and accepted to reflect most 
properties of the whole heart [13, 14]. Our data therefore 
clearly suggests that under some of the conditions studied, 
beat-to-beat variability can actively contribute to cardiac 
contractile strength. For this proof of principle investigation, 
our focus was on the effects seen on developed force. 
Changes in diastolic force were not addressed and should be 
subjected to further investigation.  
  Post-rest potentiation [4, 15] experiments have shown 
that when stimulation is interrupted and re-established, the 
contractile strength of the first beat after the period of non-
stimulation greatly depends on the duration of rest. This is 
very similar to what we observed, albeit in a much smaller 
time domain. Where post-rest experiments typically are as-
sessed from 1 to 120 seconds, we observed a similar behav-
ior for the short periods of rest (in case of variable beat dura-
tion exceeding the average heart-rate), or lack of rest (in case 
of beat duration shorter than the average heart-rate), within 
the sub-second/millisecond domains. Thus, although our 
results were obtained in a much smaller temporal domain, 
they are in line with the post-rest potentiation observations. 
  The molecular regulation of the phenomenon of positive 
inotropic beat-to-beat variability has to be sought in the 
regulation of calcium handling. The observed beat-to-beat 
variation in force correlated very closely with the calcium 
transient amplitude. This was expected, as regulation of cal-
cium handling is at the basis of post-rest potentiation. Post-
rest potentiation occurs by Ca
2+ loading of the SR during the 
rest interval. At the same time, at the level of the Na
+/Ca
2+ 
exchanger (NCX) an increase in intracellular calcium will 
lead to increase in activity which can decrease the intracyto-
solic calcium. Since both the function of the SR calcium 
ATPase and the NCX are influenced by many factors, in-
cluding phosphorylation potential, transmembrane sodium 
gradient, and the cytosolic calcium level the competition 
between the sarcoplasmic reticulum (SR) calcium ATPase 
and the Na
+/Ca
2+ exchanger (NCX) all contribute to the de-
velopment of the subsequent calcium transient. Several of 
these factors in turn change within the time-domain of inter-
est. Thus, the resulting SR calcium load highly depends on 
many, rapidly changing, factors, and it is thus likely that 
there is not a simple linear relationship between SR calcium 
load and inter-beat duration. We speculate that a variable 
inter-beat duration therefore likely causes a small positive 
effect on the SR Calcium ATPase, this allows for more cal-
cium to be available for s subsequent transient/beat resulting 
in the elevated average calcium transient. Moreover, at dif-
ferent heart rates, the above factors that modulate SR cal-
cium ATPase and NCX activity are affected differently, im-
pacting on the effect of beat-to-beat variability on contractil-
ity, as observed with a gradual effect of variability over the 
measured frequency range. It is thought that this differential 
effect on the modulating factors is highly responsible for the 
differences found between 4Hz, 6Hz and 8HZ 
  Calcium is one of the most prominent signaling ions, and 
it is likely that an introduction of beat-to-beat variability that 
changes the intracellular calcium homeostasis may have sec-
ondary effects. Through various signaling mechanisms and 
resulting changes in protein expression, introduction of beat-
to-beat variability may have secondary effect, but to deter-
mine these were well beyond the scope of this proof-of-
principle investigation.  
  In vivo, beat-to-beat variation occurs naturally, and has 
been termed heart rate variability (HRV). Although the un-
derlying principle of our studies may be similar to those un-
derlying HRV, we cannot unambiguously extrapolate our 
results to the in vivo situation, and whether introduction of 
beat-to-beat variation will have a beneficial effect in vivo in 
humans cannot be answered with this proof-of-principle in-
vestigation. Still, HRV is known to correlate with cardiac 
dysfunction. When humans age HRV becomes depressed 
[16]. A similar reduction in HRV is observed in patients suf-
fering from end-stage cardiac failure [17-19]. If this reduc-
tion in HRV can be altered by introduction of an increase in 
the interbeat variability, this may potentially offer a novel 
therapeutic corridor. While there have been reports that ir-
regular pacing may potentially worsen cardiac function in 
some patients [20-22] no direct measure of contractility was 
 
 
 
 
 
 
Fig. (5). At an average cycle rate of 125 ms (8 Hz), a variation in inter-beat duration of 40% was applied. The correlation between the devel-
oped calcium transient and peak active force development (Fdev) is shown in panel A (R
2 = 0.57, p=0.03) . Panel B demonstrates the positive 
correlation between the variations in cycle length and the developed calcium transients (R
2 = 0.72, p=0.0006). In panel C, the top and bottom 
panel show the resulting intracellular calcium transients and twitch contractions respectively. The variation in inter-beat duration is associ-
ated with variations in the calcium transients. 104    The Open Cardiovascular Medicine Journal, 2008, Volume 2  Torres et al. 
obtained. It remains unclear whether these results were in 
fact due to a decrease in contractility or to other associated 
factors such as inter and intraventricular dyssynchrony due 
to RV pacing, variable ventricular filling, and resulting load-
ing conditions or other systemic effects. Thus, although it 
remains unresolved whether beat-to-beat variation could 
have similar effects in vivo. We show that under near physio-
logical conditions and in a multicellular preparation that pre-
serves most of the fundamental components of the myocar-
dium, beat-to-beat variations can introduce an inotropic ef-
fect  in vitro with corresponding changes in the measured 
calcium transients. 
CONCLUSION 
  In conclusion, our data suggest that interbeat duration 
can, under certain conditions, be a determinant and modula-
tor of cardiac contractility.  
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